5 results
Primary objectives:Dose Escalation• To assess the safety and tolerability of JDQ443 single agent and JDQ443 in combination with TNO155, JDQ443 in combination with tislelizumab, and JDQ443 in combination with TNO155 and tislelizumab, and to identify…
Main goal:The main goal of the study is to show the feasibility of using Doppler US derived patient specific velocity profile in the abdominal aorta, carotid artery and femoral artery, in order to improve the Fluid-Structure-Interaction models of…
Primary objective:- To compare the efficacy of zanidatamab in combination with chemotherapy or in combination with chemotherapy and tislelizumab to the efficacy of trastuzumab in combination with chemotherapy in subjects with unresectable locally…
To investigate the feasibility and safety of the DMUA-HIFU system for treatment of atherosclerotic plaques.
Primary:• To compare progression free survival (PFS) between Arm A (ociperlimab in combination with tislelizumab) and Arm B (pembrolizumab followed by placebo) in the Intent to Treat (ITT) Analysis Set as assessed by investigators according to…